A package of proposed regulations that included a $10.18 fee for filling most drug prescriptions was withdrawn Tuesday by the Department of Financial Services in the face of broad opposition.

The rules would have governed the practices of pharmacy benefit managers or PBMs, companies that process drug claims on behalf of health plans. As proposed, PBMs would have been required to pay pharmacies minimum benchmark prices for drugs plus a “dispensing fee” of $10.18 for each prescription.

The fee alone would have cost the companies billions per year, an expense that was likely to be passed along to health plans, employers and consumers.

The DFS proposals were supported by pharmacies, who contended that PBMs exercise too much market power and pay unfairly low reimbursements to maximize their own profits.

But a range of other stakeholders – including insurers, employers and labor unions – argued the dispensing fee and other regulations would inevitably drive up health-care costs which they are already struggling to afford.

In its comments to the department, the United Federation of Teachers warned that the dispensing fee “will irreparably  harm – and likely bankrupt – union benefit funds.” It estimated the cost to the UFT Welfare Fund at more than $20 million annually.

The New York Health Plan Association called the regulations “profoundly anti-consumer.”

They would increase the cost of pharmacy coverage for employers, union benefit funds, insurers, and individual consumers – many of whom are medically vulnerable or seniors – by an enormous amount that, in the aggregate, would be in the billions of dollars annually. The cost impact of the proposal is not speculative or subject to actuarial debate. It is basic arithmetic that is easily calculated.

The Empire Center submitted comments focused on the dispensing fee, saying the provision would “push up the cost of coverage for New Yorkers, who already pay some of the highest health premiums in the country.”

“Even if other parts of the proposed regulations lead to savings, those savings would be offset if not eliminated by the expense of mandatory dispensing fees,” the center said.

DFS gave no explanation for its decision to withdraw the regulations, which was posted 15 days after the close of the comment period on Oct. 16.

Also on Tuesday, the department announced its final adoption of separate regulations relating to the licensing of PBMs, including the reports they must file and the registration fees they must pay.

The department’s push to regulate PBMs grew out of licensing legislation that was enacted in 2021 and amended in 2022. That law called for the estate to regulate PBM pricing practices generally, but made no specific mention of establishing a dispensing fee – meaning DFS could drop that provision from future regulatory proposals.

 

About the Author

Bill Hammond

As the Empire Center’s senior fellow for health policy, Bill Hammond tracks fast-moving developments in New York’s massive health care industry, with a focus on how decisions made in Albany and Washington affect the well-being of patients, providers, taxpayers and the state’s economy.

Read more by Bill Hammond

You may also like

How Washington’s Budget Bill Will Affect Health Care in New York

UPDATE: The final version of the federal budget bill omitted a handful of provisions that had been included in earlier drafts. One would have penalized states that use their own money to provide coverage for undocumente Read More

Even With Federal Cuts, New York’s Health Funding Would Remain High

New York's health-care industry stands to lose billions of dollars in federal funding under the major budget bill being debated in Washington – a rare and jarring turn of events for a sector accustomed to steadily increas Read More

As Albany’s Session Ends, Watch for Rising Health Costs

Every session of the state Legislature brings a fresh crop of proposals that would drive up health-care costs, and 2025 is no exception. Here is a sampling of pending bills that, if Read More

House Budget Would Burst New York’s Essential Plan Bubble

The extraordinary cash bonanza associated with New York's Essential Plan – which has generated billions more than state officials were able to spend – would come to a crashing end under the budget bill advancing in Cong Read More

The House GOP’s Shrinking Budget Plan Could Still Cost New York Billions

The likely impact of federal health-care cutbacks has diminished in recent days as House Republican leaders backed away from some of their bigger-ticket proposals, reducing the estimated savings to $625 billion from previous figures of $715 billion and $8 Read More

How Medicaid ‘Expansion’ Changes Could Affect New York

As House Republicans consider cutbacks to federal Medicaid funding, their focus has turned to the so-called expansion population. Although the details of remain undetermined, the s Read More

New York’s Home Health Workforce Jumps by Another 10 Percent

New York's home health employment is continuing to soar, growing by 57,000 jobs or 10 percent from 2023 to 2024, according to newly released data from the U.S. Bureau of Labor Statistics. Read More

Immigrant Enrollment in ‘Emergency Medicaid’ Surges to 480,000

One of the biggest drivers of New York's Medicaid enrollment growth over the past decade has been "emergency Medicaid" for undocumented immigrants, newly released state records show. Read More